MTA1 and neoplasm: IHC analysis showed that JMJD5 and MTA1 are expressed in oral cancer SC179-PDTX, and these expressions were significantly downregulated after silibinin administration in clinical tumor-bearing mice compared with controls (Fig 5C and 5D).